To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Sponsored By: Representative Rep. Houchin, Erin [R-IN-9]
Introduced
Summary
Removes most of HHS's 2024 final rule on medications for opioid use disorder but preserves accreditation changes for opioid treatment programs. This bill would void the final rule published at 89 Fed. Reg. 7549 (Feb. 2, 2024) except for the portions that modify Subpart B of Part 8 of Title 42 of the Code of Federal Regulations.
Show full summary
- People in treatment and families: Accreditation changes for opioid treatment programs remain in place, while the rule's other new policies on medications for opioid use disorder would not apply.
- Opioid treatment programs and providers: Would need to follow the modified Subpart B accreditation rules but would not be subject to the final rule's other medication-related requirements.
- HHS and federal regulators: Would be limited to enforcing only the accreditation provisions from 89 Fed. Reg. 7549, with the rest of that final rule vacated.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Cancel opioid treatment rule, keep accreditation
If enacted, this bill would cancel a federal rule on medicines for opioid use disorder (89 Fed. Reg. 7549; Feb 2, 2024). Only the parts about accrediting opioid treatment programs would stay in place. Clinics and doctors would no longer follow the rest of that rule. Patients seeking these medicines could see changed or tighter access. The change would take effect upon enactment.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Rep. Houchin, Erin [R-IN-9]
IN • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in